Aduhelm (aducanumab)
Medicare officials are trying to determine whether to cover aducanumab or Aduhelm. Since last year, Medicare has been evaluating whether to pay for a new expensive drug to treat Alzheimer’s disease. The F.D.A. approved the “miracle” drug. However, aout 40% of patients who have taken it have suffered swelling or bleeding in the brain. Alzheimer’s disease is twice
Recent Comments